/Companies

Myolyn

Gainesville, US · Founded 2013 · Florida LLC · 1 known investors

Find your way into Myolyn

Sign up to see every warm intro you have to Myolyn

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Myolyn team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

MYOLYN develops Functional Electrical Stimulation (FES) technology that helps users activate muscles, build strength, and improve movement. Its systems serve people with paralysis, rehabilitation patients, active adults, and athletes across home, clinical, and training settings.

Founders & leadership

Myolyn was founded in 2013 by MATTHEW BELLMAN.

MBMATTHEW BELLMAN
MATTHEW BELLMANManager and CTO
AJALAN J. HAMLET
ALAN J. HAMLETManager and CEOAlan J. Hamlet holds a Ph.D. in dynamics, systems, and control from the University of Florida's Center for Intelligent Machines and Robotics, where he researched perception and intelligence algorithms for autonomous vehicles. He is co-founder and CEO of Myolyn, which develops Functional Electrical Stimulation technology to enable movement and independence for people with neurological disorders.

Investors · 1

Reported raises · per SEC filings

Form D private placements

$1M disclosed across 2 of 3 rounds · 2015–2020

▶$202.5KraisedApr 2020 · 4 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alan J. HamletExecutive Officer, Director
  • Matthew BellmanDirector
Offering amount
$2M
Amount sold
$202.5K
First sale
Apr 2020
Incorporated
Limited Liability Company, Florida
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$300KofferedMay 2017 · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • ALAN J. HAMLETExecutive Officer, Director
  • MATTHEW BELLMANExecutive Officer, Director
Offering amount
$300K
Incorporated
Limited Liability Company, Florida, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$837.5KraisedMar 2017 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • ALAN J. HAMLETExecutive Officer, Director
  • MATTHEW BELLMANExecutive Officer, Director
Offering amount
$1.3M
Amount sold
$837.5K
Minimum investment
$25K
First sale
May 2015
Incorporated
Limited Liability Company, Florida, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Companies working in the same space as Myolyn.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2020$212.2K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Myolyn do?
MYOLYN develops Functional Electrical Stimulation (FES) technology that helps users activate muscles, build strength, and improve movement. Its systems serve people with paralysis, rehabilitation patients, active adults, and athletes across home, clinical, and training settings.
Who founded Myolyn?
Myolyn was founded by MATTHEW BELLMAN in 2013.
Who are Myolyn's investors?
Myolyn's investors include Florida Technology Seed Capital Fund.
How much funding has Myolyn raised?
Myolyn has disclosed $1M raised across 2 of its 3 known rounds.
Where is Myolyn headquartered?
Myolyn is headquartered in Gainesville, US.